CalciMedica (CALC) Other Non-Current Liabilities (2019 - 2026)
CalciMedica's (CALC) quarterly Other Non-Current Liabilities came in at $200000.0 in Q1 2026, down 85.71% YoY from $1.4 million in Q1 2025, and down 97.5% on a QoQ basis from $8.0 million in Q4 2025.
CalciMedica (CALC) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 5 years of Other Non-Current Liabilities data on file, last reported at $200000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 85.71% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (down 85.71% YoY) and the FY2025 annual result came in at $8.0 million, up 370.59% from the prior year.
- Other Non-Current Liabilities slipped to $200000.0 in Q1 2026, from $8.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $8.0 million in Q4 2025 to a low of $200000.0 in Q1 2026.
- A 4-year average of $3.0 million and a median of $2.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities jumped 370.59% — and 2026, when it sank 85.71%.
- Tracing CALC's Other Non-Current Liabilities over 4 years: stood at $2.6 million in 2022, then tumbled by 35.73% to $1.7 million in 2024, then jumped by 370.59% to $8.0 million in 2025, then tumbled by 97.5% to $200000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $200000.0 (Q1 2026), $8.0 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 8.00 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Dec 31, 2019 | 2.16 Mn |